Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

18
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
18
Teratogenicity01:07

Teratogenicity

2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

51
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's and men's health strategies offer a shared agenda for reform.

BMJ (Clinical research ed.)·2026
Same author

Equity and Respect in Maternal and Infant Healthcare-A Report From the 2025 Venice Forum.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Corrigendum to "Sequential three-dimensional ultrasound diagnosis of a T-shaped uterus" [Eur. J. Obstet. Gynecol. Reprod. Biol. 321 (2026) 115052].

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Sequential three-dimensional ultrasound diagnosis of a T-shaped uterus.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Why investing in women's health is a societal imperative.

Lancet (London, England)·2026
Same author

Improving the electrical conductivity of Pt nanowires deposited by focused electron beam induced deposition using thermal annealing.

Nanotechnology·2026

Related Experiment Video

Updated: Jul 26, 2025

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.4K

Recurrent MiscarriageGreen-top Guideline No. 17.

Lesley Regan, Rajendra Rai, Sotirios Saravelos

    BJOG : an International Journal of Obstetrics and Gynaecology
    |June 19, 2023
    PubMed
    Summary

    Recurrent miscarriage evaluation includes testing for acquired thrombophilia and uterine anomalies. Lifestyle advice and specific treatments like aspirin and heparin are recommended for certain conditions, while routine screening for others is not advised.

    More Related Videos

    Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
    07:46

    Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

    Published on: October 13, 2023

    1.3K
    Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
    03:01

    Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

    Published on: August 2, 2024

    753

    Related Experiment Videos

    Last Updated: Jul 26, 2025

    Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
    05:16

    Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

    Published on: August 4, 2021

    3.4K
    Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
    07:46

    Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

    Published on: October 13, 2023

    1.3K
    Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
    03:01

    Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

    Published on: August 2, 2024

    753

    Area of Science:

    • Reproductive Medicine
    • Genetics
    • Immunology

    Background:

    • Recurrent miscarriage (RM) affects a significant number of women, impacting reproductive outcomes.
    • Current guidelines recommend specific evaluations and interventions for women experiencing recurrent pregnancy loss.

    Purpose of the Study:

    • To provide evidence-based recommendations for the evaluation and management of recurrent miscarriage.
    • To clarify which diagnostic tests and treatments are appropriate for women with recurrent pregnancy loss.

    Main Methods:

    • Systematic review of existing literature and expert consensus.
    • Grading of recommendations based on evidence quality (Grades A-D, GPP).

    Main Results:

    • Testing for acquired thrombophilia (lupus anticoagulant, anticardiolipin antibodies) is recommended prior to pregnancy.
    • Cytogenetic analysis of pregnancy tissue and parental karyotyping are advised in specific circumstances.
    • Assessment for congenital uterine anomalies and thyroid dysfunction is recommended.
    • Lifestyle modifications including BMI, smoking cessation, and reduced alcohol/caffeine intake are advised.
    • Treatment with aspirin and heparin is recommended for antiphospholipid syndrome, but not for unexplained RM.
    • Progestogen supplementation may be considered for bleeding in early pregnancy.

    Conclusions:

    • A targeted approach to recurrent miscarriage evaluation is crucial.
    • Specific tests and treatments improve outcomes for certain causes of RM.
    • Avoidance of routine, non-evidence-based screening is emphasized.